Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage therapy plus standard treatment versus placebo plus standard treatment for Staphylococcus aureus-infected diabetic foot ulcers
2022-500541-24-00Phase 2Authorised
- Sponsor
- CHU Nîmes
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) and Staphylococcus aureus infection comparing Phage therapy plus standard treatment with Placebo plus standard treatment (2 arms). Planned start Jul 2024; status: authorised.
02
Drugs
bacteriophages
03
Conditions
diabetic foot ulcer (DFU)Staphylococcus aureus infection
Beyond the preview
Go deeper on 2022-500541-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500541-24-00.